Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Companies
Patients
Investigators
Trials & Research
Regulatory
Therapeutics
Companies
LATEST NEWS
Debiopharm inks deal with INC Research
26 July 2011
The CRO INC Research has formed a strategic partnership with Swiss biopharmaceutical company Debiopharm , which will see the CRO manage a clinical study for Debio 0932, while both have agreed a framework for INC's collaboration on future trials. INC Research will be firstly working on a trial for ...
Icon rejects Pfizer's Sandwich, but is hungry for 800 of its staff
21 July 2011
In a Q2 earnings call with analysts, Icon CEO Peter Gray made it clear that the CRO will not take on Pfizer 's facility in Sandwich, UK, as part of the preferred partnership deal it signed with the pharmaceutical giant at the end of May, that will see the research sponsor cull its strategic ...
INC Research completes $232 million Kendle buy
14 July 2011
INC Research has completed its $232 million acquisition of rival CRO Kendle , and by doing so more than doubles its headcount and increases its global presence to more than 100 countries. Prior to the acquisition INC Research had around 2000 employees, with Kendle being the bigger player, employing ...
Sanofi collaborates with UBC and Medco to improve outcomes research
23 June 2011
The CRO UBC and parent company Medco Health Solutions have entered into an agreement with Sanofi-Aventis to allow the pharma company to leverage the real-world evidence generated during product development, and throughout the product lifecycle, to improve the overall quality of patient care. Under ...
>> More Latest News...
FEATURES
EndPoint: Dan Weng
28 February 2011
Dr Dan Weng is Medpace 's new vice-president of operations in Asia, the Pacific Rim, Latin America and South Africa (its 'Rest of World' segment). He is charged with driving the firm's growth in emerging markets. Weng, a graduate of China's Tongji Medical University , has more than 25 years of ...
Building global organisations: adding value through people
03 September 2010
The pharmaceutical world is in a phase of massive re-structuring in an effort to reduce costs, improve efficiencies, shorten product development timelines and bring an increasing number of innovative products to the market quickly. What can the pharmaceutical companies and CROs do to make their ...
Innovative outsourcing: finding a model fit for the 21st century(Update)
06 May 2010
"Great medicines come from great minds, innovation and cultures that support innovation. The innovating company must continue to move, it is critical for the delivery of new medicines." It is very clear when talking to Dr Andrew Dahlem, chief operating officer of Lilly Research Laboratories, that ...
EndPoint: Nicola Murgatroyd
30 October 2009
Nicola founded Phlexglobal in 1997. The CRO provides logistical, clinical and administrative support to the clinical research industry and employs up to 200 staff. Nicola has 20 years experience in the pharmaceutical industry and has been instrumental in pioneering the role of the clinical trial ...
>> More Features...
PEOPLE
Biotec hires project managers to support growth
23 June 2011
The clinical trials supply company Biotec Services International , has appointed two new project managers to strengthen the company’s expanding team. Clare Aubrey and Nicola Jenkins have been tasked with dealing with the increasing number of studies which are being undertaken by Biotec, which will ...
PharmaNet's Maida joins OncoSec board
22 June 2011
OncoSec Medical , a therapeutic oncology company developing its advanced-stage ElectroOncology therapies to treat solid tumour cancers, has appointed Dr Anthony Maida to its board of directors and chair of its audit committee. Dr Maida was most recently vice-president of clinical research and ...
CRO veteran joins Waife & Associates
22 June 2011
Waife & Associates , change management consultants in clinical research, has appointed Mark Di Ianni , of MDI Consulting Services , to head up its service provider management practice. Di Ianni has been a senior executive in the CRO industry for 30 years, founding and/or managing a series of ...
>> More People...
COMMENTARY
Portfolio strategies for maximum effect
If your company is fortunate enough to have multiple projects in your development pipeline, and assuming that you do not have an unlimited resource pool, then you will be faced with some critical choices as to which projects to support and which projects not to support. Support of a project ...
ICH-GCP: older but perhaps not wiser
The ICH Harmonised Tripartite Guideline for Good Clinical Practice E6(R1), to give it its full name, was adopted in Europe in 1996 (and in the US and Japan the following year). The aim of ICH-GCP is to provide a unified standard for the EU, the US and Japan to facilitate the mutual acceptance of ...
Breathing new life into the COPD market
Chronic obstructive pulmonary disease (COPD) is an umbrella term that refers to chronic lung diseases that share the common feature of restricted airflow. According to the most recent estimates from the WHO, there are currently 210 million COPD patients worldwide, of whom 80 million have moderate ...
Prevention is better than cure
Safety concerns are never far from view where pharmaceutical R&D is concerned. Early pre-clinical testing helps to determine whether a new substance is likely to cause serious adverse events in humans, and whether it should be progressed to clinical trials. While this has been the case for many ...
Excellence in site identification begins at home
We are all aware of a sponsor’s requirement to select investigators who are, as it states in the US Code of Federal Regulations, "qualified by training and experience as appropriate experts to investigate the drug" 1 in accordance with good clinical practices. However, the current competitive ...
Acne market fails to excite
Acne, the scourge of teenagers, is a chronic condition associated with blockage of the pilosebaceous ducts typically on the face, chest and back. The blockage is manifested as a comedo or ‘blackhead’ – the pigmentation is caused by melanin arising from the hair. In cases with more severe blockage ...
>> More Commentary...
About Us
Getting Started
Subscribe
FREE Trial
Advertise
Awards
White Papers
EVENTS
Expecting data for this section.
